Bacterial footprints in aspirate of infarct-related artery in ST-elevation myocardial infarction patients underwent primary percutaneous coronary intervention

被引:6
作者
Farghaly, Ahmad A. A. [1 ]
Algowhary, Magdy [1 ]
Abdelrhman, Mohamed Z. [2 ]
Hasan-Ali, Hosam [1 ]
Dimitry, Salwa R. [1 ]
机构
[1] Assiut Univ, Fac Med, Dept Cardiovasc Med, Asyut 71515, Egypt
[2] Assiut Univ, Fac Med, Dept Clin Pathol & Immunol, Asyut, Egypt
关键词
bacterial infection; myocardial infarction; thrombus aspiration; INFLAMMATION; INFECTION; PATHOGENS; UPDATE;
D O I
10.1097/MCA.0000000000000751
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Bacterial infections can trigger acute coronary syndromes. This study aimed to examine bacterial footprints in the aspirate of infarct-related artery. Patients and methods We studied 140 patients with ST-elevation myocardial infarction who underwent a primary coronary intervention using thrombus aspiration catheters. The aspirate was sent for bacteriological and pathological examinations and immunoassay for pneumolysin toxin. Results Bacterial culture showed different bacteria in 14 samples. Leukocyte infiltrate was detected in all pathologically examined samples. Pneumolysin toxin was detected in only two samples. Patients with bacteria had similar baseline data as those without, except for the median age [46 (44-50) vs. 55 (47-62) years, P = 0.001, respectively], and white blood cells (WBCs) (16670 vs. 7550 cells/mu l, P < 0.0001, respectively). In hospital-major clinical events (death, stroke, reinfarction, lethal arrhythmia, and heart failure) were not significantly different between the 2 groups with and without bacteria [4 (28.6%) vs. 20 (18.6%) events, respectively, odds ratio (OR) 1.8 (95% CL: 06-6.3), P = 0.5]. Patients with bacteria, heavy infiltration, and pneumolysin had insignificant higher events compared with those without [10/35 (28.6%) vs. 16/105 (15.2%) events, OR 2.2 (95% CL: 0.92-5.43), P = 0.13]. However, the difference was not significant. By multivariate analysis, bacteria, leukocyte infiltration, and pneumolysin were not predictors for in-hospital clinical events. Higher WBCs and younger age were significant predictors of bacterial footprints (P < 0.0001 and P = 0.04, respectively). Conclusion Bacterial footprints existed in the aspirate of infarct-related artery of ST-elevation myocardial infarction patients. Predictors were higher WBCs and younger age. Bacterial markers were not predictors for in-hospital clinical events. The presence of bacterial footprints supports the infectious hypothesis of atherosclerosis.
引用
收藏
页码:494 / 498
页数:5
相关论文
共 50 条
  • [31] 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
    Levine, Glenn N.
    Bates, Eric R.
    Blankenship, James C.
    Bailey, Steven R.
    Bittl, John A.
    Cercek, Bojan
    Chambers, Charles E.
    Ellis, Stephen G.
    Guyton, Robert A.
    Hollenberg, Steven M.
    Khot, Umesh N.
    Lange, Richard A.
    Mauri, Laura
    Mehran, Roxana
    Moussa, Issam D.
    Mukherjee, Debabrata
    Ting, Henry H.
    O'Gara, Patrick T.
    Kushner, Frederick G.
    Ascheim, Deborah D.
    Brindis, Ralph G.
    Casey, Donald E., Jr.
    Chung, Mina K.
    de Lemos, James A.
    Diercks, Deborah B.
    Fang, James C.
    Franklin, Barry A.
    Granger, Christopher B.
    Krumholz, Harlan M.
    Linderbaum, Jane A.
    Morrow, David A.
    Newby, L. Kristin
    Ornato, Joseph P.
    Ou, Narith
    Radford, Martha J.
    Tamis-Holland, Jacqueline E.
    Tommaso, Carl L.
    Tracy, Cynthia M.
    Woo, Y. Joseph
    Zhao, David X.
    Halperin, Jonathan L.
    Levine, Glenn N.
    Anderson, Jeffrey L.
    Albert, Nancy M.
    Al-Khatib, Sana M.
    Birtcher, Kim K.
    Bozkurt, Biykem
    Brindis, Ralph G.
    Cigarroa, Joaquin E.
    Curtis, Lesley H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (10) : 1235 - 1250
  • [32] Association of thrombocytopenia and infection in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention
    Wang, Litao
    Su, Weijiang
    Xue, Jinhua
    Gong, Xiao
    Dai, Yining
    Chen, Jiyan
    Xue, Ling
    He, Pengcheng
    Liu, Yuanhui
    Tan, Ning
    BMC CARDIOVASCULAR DISORDERS, 2021, 21 (01)
  • [33] 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
    Levine, Glenn N.
    Bates, Eric R.
    Blankenship, James C.
    Bailey, Steven R.
    Bittl, John A.
    Cercek, Bojan
    Chambers, Charles E.
    Ellis, Stephen G.
    Guyton, Robert A.
    Hollenberg, Steven M.
    Khot, Umesh N.
    Lange, Richard A.
    Mauri, Laura
    Mehran, Roxana
    Moussa, Issam D.
    Mukherjee, Debabrata
    Ting, Henry H.
    O'Gara, Patrick T.
    Kushner, Frederick G.
    Ascheim, Deborah D.
    Brindis, Ralph G.
    Casey, Donald E., Jr.
    Chung, Mina K.
    de Lemos, James A.
    Diercks, Deborah B.
    Fang, James C.
    Franklin, Barry A.
    Granger, Christopher B.
    Krumholz, Harlan M.
    Linderbaum, Jane A.
    Morrow, David A.
    Newby, L. Kristin
    Ornato, Joseph P.
    Ou, Narith
    Radford, Martha J.
    Tamis-Holland, Jacqueline E.
    Tommaso, Carl L.
    Tracy, Cynthia M.
    Woo, Y. Joseph
    Zhao, David X.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2016, 87 (06) : 1001 - 1019
  • [34] Effect of ramipril on progression of nonculprit lesions in patients with ST-elevation myocardial infarction after primary percutaneous coronary intervention
    Wang, Jian
    He, Song-Yuan
    JOURNAL OF GERIATRIC CARDIOLOGY, 2019, 16 (09) : 695 - 700
  • [35] Red or White Thrombus in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Does it Matter?
    Quadros, Alexandre S.
    Cambruzzi, Eduardo
    David, Renato
    Sebben, Juliana
    Abelin, Anibal
    Welter, Dulce
    Sarmento-Leite, Rogerio
    Lopes, Renato D.
    Gottschall, Carlos A.
    CIRCULATION, 2011, 124 (21)
  • [36] Primary percutaneous coronary intervention for ST-elevation myocardial infarction: From clinical trial to clinical practice
    Rasoul, Saman
    Ottervanger, Jan Paul
    de Boer, Menko-Jan
    Dambrink, Jan-Henk E.
    Hoorntje, Jan C. A.
    Gosselink, A. T. Marcel
    Zijlstra, Felix
    Suryapranata, Harry
    van 't Hof, Arnoud W. J.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 134 (01) : 104 - 109
  • [37] Outcomes of primary percutaneous coronary intervention for acute ST-elevation myocardial infarction in patients aged over 75 years
    Zhang Qi
    Zhang Rui-yan
    Zhang Jian-Sheng
    Hu Jian
    Yang Zhen-kun
    Zheng Ai-fang
    Zhang Xian
    Shen Wei-Feng
    CHINESE MEDICAL JOURNAL, 2006, 119 (14) : 1151 - 1156
  • [38] ST changes before and during primary percutaneous coronary intervention predict final infarct size in patients with ST elevation myocardial infarction
    Terkelsen, Christian Juhl
    Kaltoft, Anne Kjer
    Norgaard, Bjarne Linde
    Bottcher, Morten
    Lassen, Jens Flensted
    Clausen, Karrina
    Nielsen, Soren Steen
    Thuesen, Leif
    Nielsen, Torsten Toftegaard
    Botker, Hans Erik
    Andersen, Henning Rud
    JOURNAL OF ELECTROCARDIOLOGY, 2009, 42 (01) : 64 - 72
  • [39] Contemporary use of adjunctive thrombectomy during primary percutaneous coronary intervention for ST-elevation myocardial infarction in the united states
    Owan, Theophilus E.
    Roe, Matthew T.
    Messenger, John C.
    Dai, David
    Michaels, Andrew D.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2012, 80 (07) : 1173 - 1180